Business ❯ Pharmaceutical Industry ❯ Drug Development

Clinical Research

Market Competition Partnerships Market Analysis Market Withdrawal Market Approval UCB SA Novo Nordisk MindMed Drug Safety Veterinary Drugs Market Competitiveness Market Impact AstraZeneca Global Trials Eli Lilly and Co Stock Performance Lykos Therapeutics

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

The drug targets chondrosarcoma, a rare bone cancer with no approved therapies.

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.